Loading clinical trials...
Loading clinical trials...
Randomized Controlled Pivotal Trial of Autologous Bone Marrow Cells Using the CardiAMP Cell Therapy System in Patients With Refractory Angina Pectoris and Chronic Myocardial Ischemia (CardiAMP CMI Trial)
Conditions
Interventions
CardiAMP Cell Therapy System
Sham Treatment
Locations
2
United States
University of Florida
Gainesville, Florida, United States
University of Wisconsin Madison
Madison, Wisconsin, United States
Start Date
June 30, 2021
Primary Completion Date
February 19, 2025
Completion Date
December 1, 2027
Last Updated
January 6, 2026
NCT06571370
NCT04306237
NCT05174572
NCT04915157
NCT02462330
NCT03438500
Lead Sponsor
BioCardia, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions